NVO - Novo Nordisk A/S

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0022
Avg. Estimate002.632.79
Low Estimate002.62.6
High Estimate002.672.97
Year Ago EPS0.580.592.332.63
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts0022
Avg. EstimateN/AN/A17.98B19.14B
Low EstimateN/AN/A17.92B18.61B
High EstimateN/AN/A18.03B19.68B
Year Ago SalesN/AN/A16.92B17.98B
Sales Growth (year/est)N/AN/A6.20%6.50%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.0.530.60.610.58
EPS Actual0.580.590.630.53
Difference0.05-0.010.02-0.05
Surprise %9.40%-1.70%3.30%-8.60%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate002.632.79
7 Days Ago002.632.79
30 Days Ago002.652.8
60 Days Ago002.652.8
90 Days Ago002.650
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesNVOIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.42
Next Qtr.N/AN/AN/A0.39
Current Year12.90%N/AN/A0.20
Next Year6.10%N/AN/A0.10
Next 5 Years (per annum)7.50%N/AN/A0.12
Past 5 Years (per annum)7.57%N/AN/AN/A